These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20008208)

  • 1. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
    Green D
    Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between venous thrombosis and dyslipidemia].
    García Raso A; Ene G; Miranda C; Vidal R; Mata R; Llamas Sillero MP
    Med Clin (Barc); 2014 Jul; 143(1):1-5. PubMed ID: 24183115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
    Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG
    J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
    Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between venous and arterial thrombosis: clinical implications.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Jun; 23(4):333-7. PubMed ID: 22560380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
    Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
    Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
    Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
    Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.
    Sørensen HT; Horvath-Puho E; Pedersen L; Baron JA; Prandoni P
    Lancet; 2007 Nov; 370(9601):1773-9. PubMed ID: 18037081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
    Za T; De Stefano V; Rossi E; Petrucci MT; Andriani A; Annino L; Cimino G; Caravita T; Pisani F; Ciminello A; Torelli F; Villivà N; Bongarzoni V; Rago A; Betti S; Levi A; Felici S; Gentilini F; Calabrese E; Leone G;
    Br J Haematol; 2013 Mar; 160(5):673-9. PubMed ID: 23240810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.
    Glynn RJ; Rosner B
    Am J Epidemiol; 2005 Nov; 162(10):975-82. PubMed ID: 16207808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.
    Brækkan SK; Hald EM; Mathiesen EB; Njølstad I; Wilsgaard T; Rosendaal FR; Hansen JB
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):487-91. PubMed ID: 22075253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between red cell distribution width and risk of venous thromboembolism.
    Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
    Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to adult evidence.
    Goldenberg NA
    Hematology Am Soc Hematol Educ Program; 2008; ():236-44. PubMed ID: 19074089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.